Organ donation: The man waiting on his third transplant
Fez is hoping new organ donation laws might mean he could get his third kidney soon.
Decreasing or eliminating time on dialysis and expediting kidney transplant are prime objectives when caring for chronic kidney disease sufferers,1 particularly since longer wait times on dialysis are associated with higher mortality rates. While influence of online patient portal (OPP) participation has been studied in other patient populations,2,3 and other tools of patient engagement have been evaluated in transplant candidates on the waitlist,4 this is the first study focused on OPP in waitlist kidney candidates and its effect on kidney transplantation wait time.
Publication date: 23–29 May 2020Source: The Lancet, Volume 395, Issue 10237Author(s): Birgit Sawitzki, Paul N Harden, Petra Reinke, Aurélie Moreau, James A Hutchinson, David S Game, Qizhi Tang, Eva C Guinan, Manuela Battaglia, William J Burlingham, Ian S D Roberts, Mathias Streitz, Régis Josien, Carsten A Böger, Cristiano Scottà, James F Markmann, Joanna L Hester, Karsten Juerchott, Cecile Braudeau, Ben James
Publication date: 23–29 May 2020Source: The Lancet, Volume 395, Issue 10237Author(s): Angus W Thomson, Amit D Tevar
CONCLUSION: Lockdown and postponement of non-urgent scheduled urological procedures decisions has led to a drastic decrease in surgical activity in AP-HP. Isolated kidney transplantation has been stopped (national statement). Urologists must anticipate for lockdown exit in order to catch-up delayed surgeries. LEVEL OF EVIDENCE: 3. PMID: 32430140 [PubMed - as supplied by publisher]
No abstract available
No abstract available
Conclusions. In the modern direct-acting antiviral era, calculated likely KDPI overestimates risk kidneys from HCV (+) donors. Donor viremia conveys an early risk which appears to subside over time. These results suggest that it may be time to revise the kidney donor risk index.
We examined the 10-year experience of Mayo Clinic's kidney paired donation (KPD).We aimed to determine the benefits for the recipients of enrolled ABO/HLA compatible pairs and determine the factors associated with prolonged KPD waiting time. Methods. We performed a retrospective study of 332 kidney transplants facilitated by the Mayo 3-site KPD program from September 2007 to June 2018. Results. The median (interquartile range) time from KPD entry to transplantation was 89 days (42-187 days). The factors independently associated with receiving a transplant>3 months after KPD entry included recipient blood type O an...
Conclusions. Seamless sharing is within reach, even when kidneys are shipped long distances for highly sensitized recipients. Late reallocations can be almost entirely avoided with a strategy that relies heavily on VXM.
Conclusions. The key comorbidities that predict poorer 2-year survival outcomes after kidney transplantation have been identified in this large prospective cohort study. The findings will facilitate assessment of individual patient risks and evidence-based decision making.